Articles
Plain explanations of what these assessments measure, written for the person having them and for the clinician reading the report.
-
Blastocystis Hominis Treatment: When a Stool Finding Changes Care
Detection rates rose and outcomes did not. Who a positive stool finding should change management for, what repeated courses cost, and which host measurements to order instead.
-
Gut Microbiome Test Results: What They Cannot Measure
A gut microbiome test takes attendance in one sample. What the highlighted organisms actually mean, why they are not Measura tests, and what can be measured in you instead.
-
Circadian Misalignment in Shift Workers: A Screening Framework
Misalignment and short sleep are different exposures. Which shift workers to screen, which metabolic and autonomic measures fit, what goes to a sleep lab, and how to document it.
-
Night Shift Health Risks You Can Actually Measure
Night shifts move insulin, appetite and inflammation within days, and rotation matters more than nights alone. What a checkup misses and which measurements show it.
-
Visceral Adiposity: Screening for the Risk That BMI Misclassifies
Imaged visceral fat predicts cardiovascular disease and cancer after adjusting for BMI. Who to screen, why cytokine blockade fails the depot, and where Crohn’s measurement stops.
-
Ultra-Processed Food: Measure the Host, Not the Additive
Additive exposure has no clinical assay. What the emulsifier and ultra-processed cohorts support, why glycemic control modifies the effect, and which measurements document the host before a dietary change.
-
Short-Chain Fatty Acids: Why a Fecal Panel Misleads
A fecal short-chain fatty acid value samples the fraction the colon did not absorb. What the founding percentage measured, what fiber and deprescribing evidence supports, and what to measure instead.